Summary Background Tuberculosis is the world's leading infectious disease killer. We aimed to identify shorter, safer drug regimens for the treatment of tuberculosis. Methods We did a randomised controlled, open-label trial with a multi-arm, multi-stage design. The trial was done in seven sites i…